エンドウ シュンジ
Shunji Endo
遠藤 俊治 所属 川崎医科大学 医学部 臨床医学 消化器外科学 職種 准教授 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Gastric neuroendocrine tumors in our institutions according to the WHO 2010 classification. |
掲載誌名 | 正式名:International surgery 略 称:Int Surg ISSNコード:25202456/00208868 |
掲載区分 | 国外 |
巻・号・頁 | 97(4),pp.335-9 |
著者・共著者 | Endo Shunji, Dousei Tsutomu, Yoshikawa Yukinobu, Hatanaka Nobutaka, Taniyama Kiyomi, Yamauchi Amane, Kamiike Wataru, Nishijima Junichi |
担当区分 | 筆頭著者 |
発行年月 | 2012/10 |
概要 | In 2010, World Health Organization classified gastric neuroendocrine tumor (NET) as follows: NET grade (G) 1, NET G2, neuroendocrine carcinoma (NEC). We reviewed 22 gastric NETs that were encountered in our institutions. Nine, 6, and 4 were NET G1, G2, and NEC, respectively. We also encountered 3 NET G3. NET G1 was treated with observation in 2 patients, endoscopic mucosal resection (EMR) in 3, and gastrectomy in 4 patients. No recurrence was experienced during a median of 53 months of follow-up. All NET G2 was treated with gastrectomy. No patient experienced recurrence during a median of 25 months of follow-up. NET G3 was treated with gastrectomy. One patient died of liver metastasis 52 months after gastrectomy. For NEC, gastrectomy was performed in 3 cases and no patients died of tumor-related death. We conclude that the prognoses of NET G1 and G2 were good. We also experienced long-term survivors of NEC. An accumulation of more patients is needed for further investigation. |
DOI | 10.9738/CC134.1 |
PMID | 23294075 |